Biomark Diagnostics Inc. (CSE: BUX)
Canada
· Delayed Price · Currency is CAD 0.200
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.35K CAD in the quarter ending September 30, 2024, a decrease of -8.97%. This brings the company's revenue in the last twelve months to 158.01K, down -0.31% year-over-year. In the fiscal year ending March 31, 2024, Biomark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
158.01K
Revenue Growth
-0.31%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.78M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| Curaleaf Holdings | 1.83B |
| WELL Health Technologies | 957.69M |
| dentalcorp Holdings | 1.51B |
| Trulieve Cannabis | 1.58B |
| Sienna Senior Living | 867.55M |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |